• Quotes

  • NAVs

  • News

  • Messages

  • Opinions

  • Notices

  • Videos

Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17193.77 -5.18 NIFTY 5106.20 -1.95
 

AstraZeneca Pharma Profit & Loss account, AstraZeneca Pharma Financial Statement & Accounts
You are here : Moneycontrol » Markets » Profit & Loss account - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820  |  NSE: ASTRAZEN  |  ISIN: INE203A01020  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Profit & Loss account of AstraZeneca Pharma

 ------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
12 mths 12 mths 12 mths 12 mths 12 mths
Income
Sales Turnover 210.90 246.95 293.69 330.51 374.34
Excise Duty 18.61 21.30 24.88 27.44 18.00
Net Sales 192.29 225.65 268.81 303.07 356.34
Other Income -0.42 7.13 6.93 9.28 12.01
Stock Adjustments -14.35 -0.68 9.85 -9.17 8.18
Total Income 177.52 232.10 285.59 303.18 376.53
Expenditure
Raw Materials 55.81 76.03 102.77 87.34 110.85
Power & Fuel Cost 1.72 1.65 2.35 2.31 2.25
Employee Cost 30.24 37.23 44.26 50.46 62.17
Other Manufacturing Expenses 2.90 4.45 0.86 1.04 1.23
Selling and Admin Expenses 28.73 32.19 37.92 46.21 49.71
Miscellaneous Expenses 9.97 10.53 16.75 14.63 24.20
Preoperative Exp Capitalised 0.00 0.00 0.00 0.00 0.00
Total Expenses 129.37 162.08 204.91 201.99 250.41
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
12 mths 12 mths 12 mths 12 mths 12 mths
Operating Profit 48.57 62.89 73.75 91.91 114.11
PBDIT 48.15 70.02 80.68 101.19 126.12
Interest 0.03 0.05 0.00 0.00 4.86
PBDT 48.12 69.97 80.68 101.19 121.26
Depreciation 4.42 5.19 5.73 5.84 6.88
Other Written Off 0.00 0.00 0.00 0.00 0.00
Profit Before Tax 43.70 64.78 74.95 95.35 114.38
Extra-ordinary items 0.00 0.00 0.00 0.00 0.00
PBT (Post Extra-ord Items) 43.70 64.78 74.95 95.35 114.38
Tax 17.94 21.72 26.21 33.89 40.54
Reported Net Profit 25.75 43.06 48.74 61.46 73.84
Total Value Addition 73.57 86.05 102.13 114.64 139.56
Preference Dividend 0.00 0.00 0.00 0.00 0.00
Equity Dividend 25.00 10.00 30.00 37.50 37.50
Corporate Dividend Tax 3.27 1.40 4.21 6.37 6.37
Per share data (annualised)
Shares in issue (lakhs) 50.00 50.00 250.00 250.00 250.00
Earning Per Share (Rs) 51.50 86.12 19.49 24.58 29.53
Equity Dividend (%) 500.00 200.00 600.00 750.00 750.00
Book Value (Rs) 191.08 254.39 56.69 63.72 46.46
Source : Religare Technova
Explore AstraZeneca connections